Albany - NY, Nov. 28, 2017 -- Growing prevalence of zoonotic diseases is projected to boost demand for veterinary chemistry analyzer globally. In addition, increasing demand to test animal-derived food products is projected to impact the global market growth of veterinary chemistry analyzers positively. Transparency Market Research states that the global market of veterinary chemistry analyzer is projected to reflect a CAGR of 7.8% over the forecast period, 2017-2022.
Factors Fuelling Global Market Growth
Growth of the global veterinary chemistry analyzers market is mainly bound to various macro-economic and micro-economic factors. Increasing population of various animals is projected to impact the global market growth of veterinary chemistry analyzer. Surge in the pet adoption is further expected to fuel demand for pet insurance and healthcare maintenance. Moreover, prevalence of diseases has further led to increasing awareness about animal healthcare globally. With the increasing awareness related to animal healthcare, demand for veterinary chemical analyzers is likely to contribute towards the global market growth. Surge in demand for animal healthcare has further led to growing number of practitioners in the veterinary hospitals and clinics. Growing need to maintain animal healthcare is projected to rev up the sales of veterinary chemical analyzer in the global market.
Growing need for conducting the hematology tests will further continue to impact the global market growth over the forecast period. As requirement for delivering accurate results and maximizing the testing facilities arises, sales for veterinary chemistry analyzer is likely to remain high globally. Increasing preference to consume animal derived edible products is further expected to boost demand for veterinary chemistry analyzer in the food industry. With the growing need to eliminate the illegal residue and contamination increases, demand for veterinary chemical analyzers is projected to increase. Imposition of regulations by FDA regarding the elimination of illegal residue and contamination in the animal food product is projected to impact the global market growth of veterinary chemistry analyzers positively. Veterinary chemistry analyzers are further used for testing various animal derived medications and prevalence of zoonotic diseases. Increasing demand for testing prevalence of various diseases in the animals is projected to contribute towards the global market growth of veterinary chemistry analyzers over the forecast period.
Get a PDF Report Sample for more Insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34976
Demand for veterinary chemistry analyzer continues to gain momentum in the global market bound to increasing prevalence of zoonotic diseases globally. A recent study by CDC reveals that tens of thousands of the Americans will fall sick due to the zoonotic diseases, which are diseases that spread between the people and animals. E.Coli infections, dengue, salmonella infection, malaria and chikungunya are some common zoonotic diseases. WHO recently revealed that malaria caused 429,000 deaths and 212 million clinical incidences in 2015. With the growing need for the control measures for zoonotic diseases increases, sales of veterinary chemistry analyzer is projected to increase significantly. Increasing demand for cheap and convenient rapid diagnostic test is projected to fuel the global market growth positively.
Sales to Remain High for Consumable Products
Increasing preference for the edible animal derived products has led to an upsurge in demand for consumable products in the global market. Based on product type, the glucometer segment is projected to reflect a robust CAGR through 2022. In terms of revenue, the consumable product type segment is projected to represent a significant growth, recording more than US$ 180 Mn by 2022-end. Representing the fastest growth, the veterinary hospitals application segment is projected to represent more around US$ 180 Mn by 2017-end.
Market Players
Major players in the global market of veterinary chemistry analyzer are Alfa Wassermann, Inc., Abaxis, Inc., Arkray, Inc., Biochemical Systems International Srl, Diasys Diagnostic Systems GmbH, Chengdu Seamaty Technology Co., Ltd., Eurolyser Diagnostica GmbH, Elitechgroup, Idexx Laboratories, Inc., Randox Laboratories Ltd.
Request for Discount on this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=34976
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



